GI197845 Posted - 2 hours ago

$ACAD Holy shart stain! How low can she go? $16.50 after hours, d'oh!

HorizonBull Posted - 3 hours ago

$ACAD

Myardiny_Toe Posted - 8 hours ago

$ACAD 🤔

Downsiderisk Posted - 1 day ago

$ACAD a TON of rumors swirling Steve Davis and Acadia are on their 9th life! This seems fitting seeing they've went 0-9 on approvals the last 8 years. Let's sum this titanic up: Daypew sales are tanking and reps are at the movies by 11am everyday. Not surprising seeing its RARE disease. Nuplazid has plateaued and no new growth over the last 6 years with a flat trend line. let's face it the only reason this dumpster fire is still going is because they thought at least 1 or 2 approvals would happen but the well is dry for old Stevie boy. No potential launch for another 4-5 years and my guess is that won't get approved either. This is why this stock is at 16 after 10 years!

DonCorleone77 Posted - 1 day ago

$ACAD Acadia Pharmaceuticals to present trofinetide findings in Rett syndrome at AAN The company states: "Acadia Pharmaceuticals announced that two oral presentations featuring DAYBUE findings in Rett syndrome will be presented at the American Academy of Neurology 2024 annual meeting, being held this week in Denver, CO. The presentations include outcomes from the DAFFODIL(TM), a Phase 2/3 open-label study evaluating the safety, tolerability and exploratory efficacy of DAYBUE in girls aged two to four living with Rett syndrome, as well as findings from exit interviews with caregivers of individuals living with Rett syndrome who participated in the LAVENDER(TM), LILAC(TM), LILAC-2(TM) and DAFFODIL studies."

Stock_Titan Posted - 1 day ago

$ACAD Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting https://www.stocktitan.net/news/ACAD/acadia-pharmaceuticals-presents-new-daybue-trofinetide-clinical-data-z5r8wqk37lkp.html

Tom1985IT Posted - 1 day ago

$ACAD this stock has been only going one way since 6 months ↘️

JRquiz Posted - 1 day ago

$ACAD Potential entry point emerging here 👀

Downsiderisk Posted - 2 days ago

$ACAD the Uncle is always right I guess. This guys has you bulls by the balls! This stock is as dead as Zeus's portfolio!

SkSk_ Posted - 3 days ago

$ACAD undervalued as heck going into ER. going to wait a few more days for more geopolitical bleeding then snag some cheap calls to cover may ER.

Downsiderisk Posted - 3 days ago

$ACAD

SBL71 Posted - 3 days ago

$ACAD nice little write up on the Bakers this AM in WSJ. Interesting they mentioned that the majority of the SGeN money was distributed back to investors as the Bakers didn’t feel there was strong enough new investment out there to deploy cash into. Hmmm.

HorizonBull Posted - 6 days ago

$ACAD 30+ after ER in may

GI197845 Posted - 6 days ago

$ACAD Wow, a new 52 week low after hours at 16.84. Did insurance stop reimbursement payments for the extremely expensive Nuplazid and Trofinetide? Wait, I know, hire more executives and have a stock inducement, or a shelf offering, or a reverse split!

Nosh Posted - 6 days ago

$ACAD And another block to clean up the stream...99% chance the same person with two accounts.

Downsiderisk Posted - 6 days ago

$ACAD stock to $10

Nosh Posted - 6 days ago

$ACAD Looking for entry at 15.50 area as support is broken...it happens it happens.

Nosh Posted - 6 days ago

$ACAD Went through the stream and blocked this guy...constant spam on the board.

VolumePrice Posted - 6 days ago

$XERS $ACAD I am buying

zeustony88 Posted - 6 days ago

$ACAD

BobBijawk Posted - 6 days ago

$IBRX I am liking an entry point on $acad . Patent protectoin on parkinons dementia for 10 more years and dayblue is the only approved drug for rhett syndrome. also a phase 3 in a ultra orphan that will be up for approval on the back end of 24 . And a phase 2 in alzheimers psychosis that if approved woudl garner a increase in stock price up to 3 fold of todays price. Annual EPS around 1.00 and revnues in the billion dollar per year range. 17 per share is a steal.

Downsiderisk Posted - 1 week ago

$ACAD

Jiffy485 Posted - 1 week ago

$ACAD Davis desperately needs to go

SBL71 Posted - 1 week ago

$ACAD @GI197845 I have seen you make remarks about this Rx before...what I think might be helpful is if you take 1 minute and think about why this Rx is important. We all have someone in our lives that has faced challenges-cancer, immune disease, cardio issue, ect ect...Rett is felt in primary young girls. Maybe just step back for one minute...before your next slap at this Rx/company and think about how lucky you are not to have any young female in your world yet affected by this disease state and what a blessing it must be to have a Tx available, even in the presence of some minor and controllable side effects. 1 minute.

GI197845 Posted - 1 week ago

$ACAD

erevnon Posted - 1 week ago

Cantor Fitzgerald reiterates ACADIA Pharmaceuticals $ACAD at Overweight and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

insiderbuyingselling Posted - 1 week ago

$ACAD new insider selling: 26574 shares. http://insiderbuyingselling.com/?t=ACAD

insiderbuyingselling Posted - 1 week ago

$ACAD new insider selling: 2568 shares. http://insiderbuyingselling.com/?t=ACAD

GI197845 Posted - 1 week ago

$ACAD Rah! Rah! Rah! The 5 million dollar research center in Sweden is paying dividends! I hope the female-children-patients are being helped by Daybue, instead of only spraying out nasty diarrhea!

erevnon Posted - 1 week ago

Needham reiterates ACADIA Pharmaceuticals $ACAD at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/